1. Home
  2. SXT vs TMDX Comparison

SXT vs TMDX Comparison

Compare SXT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXT
  • TMDX
  • Stock Information
  • Founded
  • SXT 1882
  • TMDX 1998
  • Country
  • SXT United States
  • TMDX United States
  • Employees
  • SXT N/A
  • TMDX N/A
  • Industry
  • SXT Major Chemicals
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SXT Industrials
  • TMDX Health Care
  • Exchange
  • SXT Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • SXT 4.5B
  • TMDX 3.9B
  • IPO Year
  • SXT N/A
  • TMDX 2019
  • Fundamental
  • Price
  • SXT $103.02
  • TMDX $118.18
  • Analyst Decision
  • SXT Buy
  • TMDX Buy
  • Analyst Count
  • SXT 2
  • TMDX 11
  • Target Price
  • SXT $110.00
  • TMDX $125.40
  • AVG Volume (30 Days)
  • SXT 528.9K
  • TMDX 955.0K
  • Earning Date
  • SXT 10-31-2025
  • TMDX 10-27-2025
  • Dividend Yield
  • SXT 1.63%
  • TMDX N/A
  • EPS Growth
  • SXT 53.07
  • TMDX 2163.11
  • EPS
  • SXT 3.17
  • TMDX 2.02
  • Revenue
  • SXT $1,575,588,000.00
  • TMDX $531,292,000.00
  • Revenue This Year
  • SXT $4.42
  • TMDX $38.87
  • Revenue Next Year
  • SXT $5.78
  • TMDX $20.70
  • P/E Ratio
  • SXT $31.83
  • TMDX $59.68
  • Revenue Growth
  • SXT 4.95
  • TMDX 48.09
  • 52 Week Low
  • SXT $66.15
  • TMDX $55.00
  • 52 Week High
  • SXT $121.54
  • TMDX $169.29
  • Technical
  • Relative Strength Index (RSI)
  • SXT 33.87
  • TMDX 53.37
  • Support Level
  • SXT $100.03
  • TMDX $105.00
  • Resistance Level
  • SXT $114.33
  • TMDX $121.00
  • Average True Range (ATR)
  • SXT 3.45
  • TMDX 5.35
  • MACD
  • SXT -1.32
  • TMDX 1.23
  • Stochastic Oscillator
  • SXT 33.47
  • TMDX 83.90

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: